HRS/EHRA expert consensus on the monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): Description of techniques, indications, personnel, frequency and ethical considerations - Developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC)

Europace

Volumn 10, Issue 6, 2008, Pages 707-725

  Wilkoff, Bruce L ^a   Auricchio, Angelo ^b   Brugada, Josep ^c   Cowie, Martin ^d   Ellenbogen, Kenneth A ^e   Gillis, Anne M ^f   Hayes, David L ^g   Howlett, Jonathan G ^h   Kautzner, Josef ⁱ   Love, Charles J ^j   Morgan, John M ^k   Priori, Silvia G ^l   Reynolds, Dwight W ^m   Schoenfeld, Mark H ⁿ   Vardas, Panos E ^o   Goldberg, Donna M ^p  

^a LERNER RESEARCH INSTITUTE   (United States)

^b DIVISION OF CARDIOLOGY   (Switzerland)

^c UNIVERSITY OF BARCELONA   (Spain)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^f UNIVERSITY OF CALGARY   (Canada)

^g MAYO CLINIC   (United States)

^h DALHOUSIE UNIVERSITY   (Canada)

ⁱ INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^j OHIO STATE UNIVERSITY   (United States)

^k Corner Cottage ^*  (United Kingdom)

^l Breast Unit Surgery   (Italy)

^m UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

ⁿ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^p c/o Heart Rhythm Society ^*  (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CONFERENCE PAPER; CONSENSUS; DEFIBRILLATOR; ELECTRONICS; EQUIPMENT DESIGN; EUROPE; EUROPEAN HEART RHYTHM ASSOCIATION; FOLLOW UP; FREQUENCY ANALYSIS; GOOD MANUFACTURING PRACTICE; GOVERNMENT; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART FAILURE SOCIETY OF AMERICA; HEART HEMODYNAMICS; HEART RHYTHM SOCIETY; HEMODYNAMIC MONITORING; IMPLANT REGISTRY; INSTRUMENT VALIDATION; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL SOCIETY; MEDICAL TECHNOLOGY; MONITOR; MONITORING; NORTH AMERICA; PRIORITY JOURNAL; QUALITY OF LIFE; REIMBURSEMENT; SAFETY; TECHNIQUE; TREATMENT INDICATION;

CONSENSUS; DEFIBRILLATORS, IMPLANTABLE; EUROPE; PACEMAKER, ARTIFICIAL; PRACTICE GUIDELINES AS TOPIC; PRODUCT SURVEILLANCE, POSTMARKETING; QUALITY ASSURANCE, HEALTH CARE;

EID: 44649122064     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun122     Document Type: Conference Paper

References (61)

1. Source: EUCOMED (European Medical Technology Industry Association) unpublished data, website at: http://www.eucomed.be/.
2. Hayes DL, Naccarelli GV, Furman S, Parsonnet V, Reynolds D, Goldschlager N, Gillette P, Maloney JD, Saxon L, Leon A, Daoud E, North American Society of Pacing and Electrophysiology. NASPE training requirements for cardiac implantable electronic devices: selection, implantation, and follow-up. Pacing Clin Electrophysiol 2003;26(7 Pt 1):1556-62.
3. Nacarelli GV, Conti JB, DiMarco JP, Tracy CM. 2008 COCATS 3 Task Force 6: training in specialized electrophysiology, cardiac pacing, and arrhythmia management. Heart Rhythm 2008;5:332-7.
4. Hayes JJ, Juknavorian R, Maloney JD. North American Society of Pacing and Electrophysiology (NASPE) Policy Statement: the role(s) of the industry employed allied professional. Pacing Clin Electrophysiol 2001;24:398-9.
5. Love CJ. Pacemaker troubleshooting and follow-up. In: Ellenbogen KA, Kay GN, Lau C-P, Wilkiff BL, editors. Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy. Third edition. Philadelphia: Saunders Elsevier, 2007, Chapter 24.
6. Fraser JD, Gillis AM, Irwin ME, Nishimura S, Tyers GF, Philippon F; Canadian Working Group on Cardiac Pacing. Guidelines for pacemaker follow-up in Canada: a consensus statement of the Canadian Working Group on Cardiac Pacing. Can J Cardiol 2000;16:355-63.
7. Gillis AM, Philippon F, Cassidy MR, Singh N, Dorian P, Love BA, Kerr CR. Canadian Working Group on Cardiac Pacing. Guidelines for implantable cardioverter-defibrillator follow-up in Canada: a consensus statement of the Canadian Working Group on Cardiac Pacing. Can J Cardiol 2003;19:21-37.
8. Winters SL, Packer DL, Marchlinski FE, Lazzara R, Cannom DS, Breithardt GE, Wilber DA, Camm AJ, Ruskin JN. North American Society of Electrophysiology and Pacing. Consensus statement on indications, guidelines for use, and recommendations for follow-up of implantable cardioverter-defibrillators. North American Society of Electrophysiology and Pacing. Pacing Clin Electrophysiol 2001;24:262-9.
9. Joseph GK, Wilkoff BL, Dresing T, Burkhardt J, Khaykin Y. Remote interrogation and monitoring of implantable cardioverter-defibrillators. J Interv Card Electrophysiol 2004;11:161-6.
10. Schoenfeld MH, Compton SJ, Mead RH, Weiss DN, Sherfesee L, Englund J, Mongeon LR. Remote monitoring of implantable cardioverterdefibrillators: a prospective analysis. Pacing Clin Electrophysiol 2004;27:757-63.
11. Schoenfeld MH, Reynolds DW. Sophisticated remote implantable cardioverter-defibrillator follow-up: a status report. Pacing Clin Electrophysiol 2005;28:235-40.
12. Brugada P. What evidence do we have to replace in-hospital implantable cardioverter-defibrillator follow-up? Clin Res Cardiol 2006;95(Suppl 3):III3-9.
13. Saxon LA, Boehmer JP, Neuman S, Mullin CM. Remote Active Monitoring in Patients with Heart Failure (RAPID-RF): design and rationale. J Card Fail 2007;13:241-6.
14. Schoenfeld MH, Reynolds DW. Sophisticated remote implantable cardioverter-defibrillator follow-up: a status report. Pacing Clin Electrophysiol 2005;28:235-240.
15. Joseph GK, Wilkoff BL, Dresing T, Burkhardt J, Khaykin Y. Remote interrogation and monitoring of implantable cardioverter defibrillators. J Interv Card Electrophysiol 2004;11:161-6.
16. Fauchier L, Sadoul N, Kouakam C, Briand F, Chauvin M, Babuty D, Clementy J. Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol 2005;28(Suppl I):S255-9.
17. Ellery S, Pakrashi T, Paul V, Sack S. Predicting mortality and rehospitalization in heart failure patients with home monitoring - the Home CARE pilot study. Clin Res Cardiol 2006;95(Suppl 3):III29-35.
18. Ricci RP, Russo M, Santini M. Management of atrial fibrillation - what are the possibilities of early detection with home monitoring? Clin Res Cardiol 2006;95(Suppl 3):III10-6.
19. Res JC, Theuns DA, Jordaens L. The role of remote monitoring in the reduction of inappropriate implantable cardioverter-defibrillator therapies. Clin Res Cardiol 2006;95(Suppl 3):III17-21.
20. Furman S. Safe Medical Devices Act of 1990. Pacing Clin Electrophysiol 1991;14:387-8.
21. Anselmann N. The European legislation on medical devices. Stud Health Technol Inform 1996;28:5-12.
22. Buxton AE, Calkins H, Callans DJ, DiMarco JP, et al. ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures. J Am Coll Cardiol 2006;48:2360-96.
23. Carlson MD, Wilkoff BL, Maisel WH, Ellenbogen KA, et al. Recommendations from the Heart Rhythm Society on Device Performance Policies and Guidelines. Heart Rhythm 2006;3:1250-73.
24. Auricchio A, Gropp M, Ludgate S, Vardas P, Brugada J, Priori SG. European Heart Rhythm Association Guidance Document on cardiac rhythm management product performance. Europace 2006;8:313-22.
25. Sorel. Sarah Medical Device Development: U.S. and EU Differences. Applied Clinical Trials. http://actmagazine.findpharma.com/ appliedclinicaltrials/article/articleDetail.jsp?id=363640.
26. Council Directive 90/385/EEC of 20 June 1990. In: http://europa.eu.int/ comm/enterprise/medical_devices/legislation_en.htm.
27. Medical Device Reporting. http://www.fda.gov/CDRH/DEVADVICE/351.html.
28. MEDDEV 2.12/1. Guidelines on a Medical Devices Vigilance System. http:/www.mdss.com/MDEV/meddev2-12.htm.
29. Guidance for Industry-Medical Device Tracking. http:/www.fda.gov/cdrh/ comp/guidance/169.html.
30. Hammill SC, Stevenson LW, Kadish AH, Kremers MS, Heidenreich P, Lindsay BD, et al. National ICD Registry Annual Report 2006 Review of the registry's first year, data collected, and future plans. Heart Rhythm 2007;4:1260-3.
31. Hayes DL, Naccarelli GV, Furman S, Parsonnet V, Reynolds D, Goldschlager N, Gillette P, Maloney JD, Saxon L, Leon A, Daoud E. North American Society of Pacing and Electrophysiology. NASPE (HRS) training requirements for cardiac implantable electronic devices: selection, implantation, and follow-up. Pacing Clin Electrophysiol 2003;26(7 Pt I):1556-62.
32. Tibi T, Moceri P, Martin Teule C, Berkane N, Talbodec A, Tannous J, Zemour G. Local registry of pacemakers implantations: proposals to decrease the infectious risk. Ann Cardiol Angeiol (Paris) 2006;55:339-41.
33. Bonhorst D, de Sousa J, Adragao P. National Registry on Cardiac Electrophysiology - 2004. Rev Port Cardiol 2006;25:353-61.
34. Silveira MJ, DiPiero A, Gerrity MS, Feudtner C. Patients' knowledge of options at the end of life: ignorance in the face of death. JAMA 2000;284:2483-8.
35. Meisel A, Snyder L, Quill T. Seven legal barriers to end-of-life care: myths, realities, and grains of truth. JAMA 2000;284:2495-501.
36. Miller FG, Fins JJ, Snyder L. Assisted suicide compared with refusal of treatment: a valid distinction? University of Pennsylvania Center for Bioethics Assisted Suicide Consensus Panel. Ann Intern Med 2000;132:470-5.
37. Lewis WR, Luebke DL, Johnson NJ, et al. Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med 2006;119:892-6.
38. Goldstein NE, Lampert R, Bradley E, et al. Management of implantable cardioverter-defibrillators in end-of-life care. Ann Intern Med 2004;141:835-8.
39. Braun TC, Hagen NA, Hatfield RE, Wyse DG. Cardiac pacemakers and implantable defibrillators in terminal care. J Pain Symptom Manage 1999;18:126-31.
40. Berger JT. The ethics of deactivating implanted cardioverter- defibrillators. Ann Intern Med 2005;142:631-4.
41. Iskos D, Lurie KG, Sakaguchi S, Benditt DG. Termination of implantable pacemaker therapy: experience in five patients. Ann Intern Med 1997;126:787-90.
42. Schoenfeld MH. Deciding against defibrillator replacement: second-guessing the past? Pacing Clin Electrophysiol 2000;23:2019- 21.
43. Gostin LO. Deciding life and death in the courtroom. From Quinlan to Cruzan, Glucksberg, and Vacco - a brief history and analysis of constitutional protection of the "right to die." JAMA 1997;278):1523-8.
44. Cancer pain relief and palliative care. In: Technical Report Series 804 World Health Organization, Geneva (1990), pp. 11-2.
45. Berger JT. The ethics of deactivating implanted cardioverter defibrillators. Ann Intern Med 2005;142:631-4.
46. Schneiderman LJ, Kaplan RM, Pearlman RA, Teetzel H. Do physicians' own preferences for life-sustaining treatment influence their perceptions of patients' preferences? J Clin Ethics 1993;4:28-33.
47. Uhlmann RF, Pearlman RA. Perceived quality of life and preferences for life-sustaining treatment in older adults. Arch Intern Med 1991;151:495-7.
48. Schneiderman LJ, Kaplan RM, Rosenberg E, Teetzel H. Do physicians' own preferences for life-sustaining treatment influence their perceptions of patients' preferences? A second look. Camb Q Healthc Ethics 1997;6:131-7.
49. Colorado Hospice Organization Position Paper: Cardiac Pacing Devices. March 2007.
50. Furrow B, Greaney T, Johnson H, Jost T, Schwartz R. Bioethics health care law and ethics. In: Life and Death Decisions: Principles of Autonomy and Beneficence. St. Paul, MN: West Group, 2001:246-263.
51. Kobza R, Erne P. End-of-life decisions in ICD patients with malignant tumors. Pacing Clin Electrophysiol 2007;30:845-9.
52. England R, Egland T, Coggon J. The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer. J Med Ethics 2007;33:538-40.
53. Guidelines for the appropriate use of do-not-resuscitate orders. Council on Ethical and Judicial Affairs, American Medical Association. JAMA 1991;265:1868-71.
54. Lewis WR, Luebke DL, Johnson NJ, et al. Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med 2006;119:892-6.
55. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace 2006;8:746-837.
56. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Heart Rhythm 2008;5.
57. Crowley G. EU and US clinical investigation adverse event reporting. Med Device Technol 2004;15:30-2.
58. Donawa M. Medical device directive: preparing for the amendments. Med Device Technol 2000;11:40-5.
59. Beholz S, Koch C, Konertz W. Quality management system of a university cardiac surgery department according to DIN EN ISO 9001: 2000. Thorac Cardiovasc Surg 2003;51:167-73.
60. Donawa M. Update on ISO 13485. Med Device Technol 2002;13:23-5.
61. ISO 13485:2003, International Organization for Standardization.